New online tool aims to ease prostate cancer treatment choices

NCT ID NCT07280897

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a web-based program called SCIPI that provides men with localized prostate cancer easy-to-understand information, communication tools, and social support. About 200 newly diagnosed patients will be randomly assigned to use SCIPI or receive usual care. Researchers want to see if SCIPI helps patients feel more confident and satisfied with their treatment decisions and improves their quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SCIPI (Support, Communication, and Information Program for Prostate Cancer - Interactive) - a web-based supportive care program
What this could lead to
If it works, this could give doctors a practical tool to help patients feel more confident and satisfied with their treatment choices.
What could go wrong
This is a small early pilot study, so results may not apply to all patients. The program may not improve decision-making or quality of life more than usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Texas Health Science Center at San Antonio School of Nursing

    San Antonio, Texas, 78229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.